| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Operating activities | ||||||
Net loss | ||||||
-39,247 | -23,846 | -10,247 | ||||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Depreciation and amortization | ||||||
174 | 105 | 96 | ||||
Stock-based compensation | ||||||
1,421 | 332 | 77 | ||||
Non-cash interest expense | ||||||
500 | 3,664 | 2,711 | ||||
Change in fair value warrant liability | ||||||
0 | -11 | -1,019 | ||||
Change in fair value derivative liability | ||||||
0 | -676 | -57 | ||||
Changes in operating assets and liabilities: | ||||||
Other receivable | ||||||
1,000 | 233 | - | ||||
Prepaid expenses and other assets | ||||||
1,954 | 1,017 | -40 | ||||
Accounts payable | ||||||
802 | 1,337 | -213 | ||||
Accrued expenses and other current liabilities | ||||||
-327 | 1,923 | 242 | ||||
Deferred rent | ||||||
37 | 17 | -3 | ||||
Net cash used in operating activities | ||||||
-39,594 | -17,053 | -8,259 | ||||
Investing activities | ||||||
Purchases of property and equipment | ||||||
960 | 119 | 216 | ||||
Net cash used in investing activities | ||||||
-960 | -119 | -216 | ||||
Financing activities | ||||||
Proceeds from issuance of common stock, net | ||||||
46,277 | 42,974 | - | ||||
Payments of deferred stock offering costs | ||||||
145 | 0 | - | ||||
Proceeds from issuance of redeemable convertible preferred stock, net | ||||||
0 | 17,712 | - | ||||
Long-term borrowings, net | ||||||
8,089 | 3,995 | 3,480 | ||||
Proceeds from exercise of stock options | ||||||
245 | 92 | 3 | ||||
Proceeds from exercise of warrants | ||||||
0 | 24 | - | ||||
Repayments of long-term debt | ||||||
938 | 0 | - | ||||
Proceeds from convertible promissory notes, net | ||||||
- | - | 14,683 | ||||
Net cash provided by (used in) financing activities | ||||||
53,528 | 64,797 | 18,166 | ||||
Net decrease in cash and cash equivalents | ||||||
12,974 | 47,625 | - | ||||
Net increase (decrease) in cash and cash equivalents | ||||||
- | - | 9,691 | ||||
Supplemental disclosure for cash flow | ||||||
Cash paid for interest | ||||||
576 | 260 | 12 | ||||
Supplemental disclosure of cash flow information | ||||||
Supplemental disclosure of non-cash investing and financing activities | ||||||
Accrued interest on term loan refinanced to principal | ||||||
308 | 0 | - | ||||
Right-of-use asset and lease liabilities recorded upon adoption of ASC 842 | ||||||
1,991 | - | - | ||||
Conversion of redeemable convertible preferred stock into common stock | ||||||
0 | 125,609 | - | ||||
Conversion of convertible promissory notes into redeemable convertible preferred stock | ||||||
0 | 19,778 | - | ||||
Warrant liability converted to redeemable convertible preferred stock upon the exercise of warrants | ||||||
0 | 4,297 | - | ||||
Issuance of warrants in conjunction with debt | ||||||
355 | 2,822 | 1,795 | ||||
Debt refinanced with new term loan | ||||||
6,563 | 0 | - | ||||
Conversion of redeemable convertible preferred stock warrants into common stock warrants | ||||||
0 | 3,346 | - | ||||
Accretion of redeemable convertible preferred stock | ||||||
0 | 95 | 67 | ||||
Deferred stock offering costs in accounts payable | ||||||
110 | 0 | - | ||||
Purchases of property and equipment included in accounts payable and accrued expenses | ||||||
823 | 39 | - | ||||
Issuance of derivative in conjunction with debt | ||||||
- | - | 2,971 | ||||